About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
J
The Latest Data on New Therapies in FL and MZL
By
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Jordan Carter
By
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Jordan Carter
55 views
March 6, 2024
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Related Content
AUTOPLAY
ON
06:33
Christopher Flowers
FDA Approval of Zanubrutinib in R/R FL: What You Need to Know
08:18
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment Strategies for Hematocrit Control…
Feat.
A. Zhou
13:56
SOHO 2023 Eleventh Annual Meeting
Follicular Lymphoma Management: What Is the New Order?
Feat.
B. Kahl
27:51
Louisville Hematology Highlights
Summary of Recent Advances in Follicular Lymphoma
Feat.
S. Gaballa
19:46
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
Management of Indolent NHL
Feat.
E. Brem
09:27
ASH 2022 Conference Coverage
MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…
Feat.
M. McMullin
17:21
Daniel Addison
Cardiovascular Considerations With (Contemporary) BTKi in the Treatm…
05:38
GRACE
Epcoritamab in NHL - Incidence and Management of CRS
Feat.
T. Phillips
08:58
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Zanubrutinib + Obinutuzumab vs. Obinutuzu…
Feat.
C. Flowers
16:25
Northwestern Medicine Oncology and Hematology
Diagnosis and Goals of Therapy in PV
Feat.
B. Stein
24:44
Indy Hematology Review
State of the Art in 2024: Emerging Therapies in Hematologic Malignan…
Feat.
R. Birhiray
31:12
UChicago Medicine
Practice-Changing Abstracts in NHL and HL From ASH 2023
Feat.
S. Smith
37:44
University of Colorado Division of Hematology
Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas
Feat.
M. Kamdar
26:58
Total Health
Update on Cellular Therapy in Lymphoma
Feat.
B. Randolph
10:36
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Epcoritamab + R² Regimen and Responses in…
Feat.
R. Merryman
33:11
Total Health
Bispecific Antibodies and CAR T-Cells for NHL: Challenges and Opport…
Feat.
K. Komanduri
10:49
Monia Marchetti
Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…
04:16
GRACE
Mosunetuzumab for R/R Follicular Lymphoma
Feat.
T. Phillips
42:09
University of Colorado Department of Medicine
Immunotherapy in Lymphomas: The Present and the Future
Feat.
M. Kamdar
06:38
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Updated Results From EPCORE NHL-1 - Effec…
Feat.
Y. Karimi